In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Medtech is seeing disruptive innovation in several areas, ranging from early cancer detection to mental health. The COVID-19 pandemic is uniquely spurring the sector to innovate more broadly.

One-Stop Shop: EU Devices And Diagnostics Regulatory Outlook Through May 2021

The end of the traditional EU holiday period is nearing, and the pace of regulatory activity is expected to pick up sharply as September gets underway. What can medtech expect for the rest of 2020 and into the first half of 2021, in these unprecedented times?

Early Cancer Detection: Will New Screening Technology Disrupt Cancer Care?

The emergence of multi-cancer blood tests for early detection is captivating investors and driving multi-billion-dollar acquisitions. Companies such as GRAIL, Thrive Earlier Detection and Guardant are predicting revolutionary change in the way cancer is diagnosed and treated. The biggest hurdle, however, may be coaxing health care systems and health insurers to join the revolution.

Eye In The Sky: GE Healthcare’s Dynamic Crisis Management Can Be Replicated in ‘Normal Times’

Real-time decision support came of age in dramatic style during COVID-19. GE Healthcare’s CEO of Clinical Command Centers Jeff Terry explains that AI- and app-based health system collaboration and virtualized care will become increasingly embedded as health care delivery transforms.

Opportunities For Medtech In Mental Health

With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. In Vivo explores transcranial magnetic stimulation systems that are being used to treat severe anxiety and depression, among other indications. As well as the skyrocketing use of telehealth, apps and light therapy for mental health indications.  

Chapter sponsored by:

COVID-19 Transforms IVD Industry From Concept To Market

The emergence of COVID-19 forced rapid change within the In Vitro Diagnostics (IVD) industry.

Download Now

About IQVIA Medtech

IQVIA MedTech is a leader in the medical device and in vitro diagnostics industry with solutions, services, and a team of industry experts who deliver highly integrated and robust MedTech-focused offerings to help orchestrate your business from concept to market.

Learn More »